跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,678 条关于
“LTG-321”
全部
9,678
临床试验
3,243
药物
2,297
机构
3,784
资讯
354
2个月前
Latigo Biotherapeutics Files for IPO as Non-Opioid Pain Drug LTG-001 Advances to Late-Stage Testing
去年
Latigo Secures $150M Series B to Advance Non-Opioid Pain Medications Through Late-Stage Trials
去年
FDA Grants Fast Track Status to Latigo's Novel Non-Opioid Pain Treatment LTG-001
去年
Latigo Bio Doses First Participant in Phase 1 Trial of Non-Opioid Pain Drug LTG-305
去年
Epicrispr Biotechnologies Doses First Patient with EPI-321, Novel Epigenetic Therapy for Facioscapulohumeral Muscular Dystrophy
2个月前
Epicrispr's EPI-321 Reaches Full Enrolment in First-in-Human Epigenetic CRISPR Therapy Trial
12个月前
FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention
去年
Epicrispr Biotechnologies Secures $68 Million to Advance First Epigenetic Therapy for FSHD
去年
Lilly's Jaypirca Shows Promise in BTK Inhibitor-Pretreated CLL/SLL
去年
Sodium Channel Blockers Pipeline Surges with 20+ Pharmaceutical Companies Developing Novel Therapies
第 1 页,共 36 页
上一页
下一页